Ronald E. Law

9.6k total citations · 2 hit papers
89 papers, 8.2k citations indexed

About

Ronald E. Law is a scholar working on Molecular Biology, Cancer Research and Immunology. According to data from OpenAlex, Ronald E. Law has authored 89 papers receiving a total of 8.2k indexed citations (citations by other indexed papers that have themselves been cited), including 65 papers in Molecular Biology, 26 papers in Cancer Research and 12 papers in Immunology. Recurrent topics in Ronald E. Law's work include Peroxisome Proliferator-Activated Receptors (34 papers), Metabolism, Diabetes, and Cancer (13 papers) and Cancer, Lipids, and Metabolism (10 papers). Ronald E. Law is often cited by papers focused on Peroxisome Proliferator-Activated Receptors (34 papers), Metabolism, Diabetes, and Cancer (13 papers) and Cancer, Lipids, and Metabolism (10 papers). Ronald E. Law collaborates with scholars based in United States, Germany and Australia. Ronald E. Law's co-authors include Willa A. Hsueh, Ulrich Kintscher, Eckart Fleck, Kristof Graf, Stephan Goetze, Xiao-Ping Xi, Dennis Bruemmer, Christopher J. Lyon, Simon Jackson and Alan R. Collins and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Circulation.

In The Last Decade

Ronald E. Law

89 papers receiving 8.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Synthetic LXR ligand inhibits the development of atherosclerosis in mice

2002 778 citations Alan R. Collins, Grace Noh et al. profile →
Minireview: Adiposity, Inflammation, and Atherogenesis

2003 586 citations Ronald E. Law, Willa A. Hsueh et al. profile →

Peers

Countries citing papers authored by Ronald E. Law

Since Specialization

Citations

This map shows the geographic impact of Ronald E. Law's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ronald E. Law with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ronald E. Law more than expected).

Fields of papers citing papers by Ronald E. Law

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ronald E. Law. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ronald E. Law. The network helps show where Ronald E. Law may publish in the future.

Co-authorship network of co-authors of Ronald E. Law

This figure shows the co-authorship network connecting the top 25 collaborators of Ronald E. Law. A scholar is included among the top collaborators of Ronald E. Law based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ronald E. Law. Ronald E. Law is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	How to create innovation by building the translation bridge from basic research into medicinal drugs: an industrial perspective 2013 ·Human Genomics ·(unknown), Alexander Schuhmacher, (unknown), Ronald E. Law, (unknown), (unknown)	12
2	Osteopontin modulates angiotensin II- induced fibrosis in the intact murine heart 2004 ·Journal of the American College of Cardiology ·Alan R. Collins, Janet Schnee, Wei Wang, Sarah Kim, Michael C. Fishbein, Dennis Bruemmer, Ronald E. Law, Susanne B. Nicholas, Robert S. Ross, Willa A. Hsueh	120
3	Egr-1 is a Major Vascular Pathogenic Transcription Factor in Atherosclerosis and Restenosis 2004 ·Reviews in Endocrine and Metabolic Disorders ·Florian Blaschke, Dennis Bruemmer, Ronald E. Law	61
4	Inhibitory Activity of Clinical Thiazolidinedione Peroxisome Proliferator Activating Receptor-γ Ligands Toward Internal Mammary Artery, Radial Artery, and Saphenous Vein Smooth Muscle Cell Proliferation 2003 ·Circulation ·(unknown), Dennis Bruemmer, Rodney J. Dilley, Melanie E. Ivey, Garry Jennings, Ronald E. Law, Peter J. Little	79
5	Angiotensin II–accelerated atherosclerosis and aneurysm formation is attenuated in osteopontin-deficient mice 2003 ·Journal of Clinical Investigation ·Dennis Bruemmer, Alan R. Collins, Grace Noh, Wei Wang, Mary Territo, (unknown), Michael C. Fishbein, Florian Blaschke, Ulrich Kintscher, Kristof Graf, Ronald E. Law, Willa A. Hsueh	246
6	Expression of minichromosome maintenance proteins in vascular smooth muscle cells is ERK/MAPK dependent 2003 ·Experimental Cell Research ·Dennis Bruemmer, Fen Yin, Joey Liu, Tohru Kiyono, Eckart Fleck, André J. Van Herle, Ronald E. Law	19
7	Thiazolidinedione regulation of smooth muscle cell proliferation 2003 ·The American Journal of Medicine ·Dennis Bruemmer, Ronald E. Law	28
8	PGE2 is generated by specific COX-2 activity and increases VEGF production in COX-2-expressing human pancreatic cancer cells 2003 ·Biochemical and Biophysical Research Communications ·Guido Eibl, Dennis Bruemmer, Yuji Okada, John P. Duffy, Ronald E. Law, Howard A. Reber, O. Joe Hines	103
9	Atorvastatin inhibits expression of minichromosome maintenance proteins in vascular smooth muscle cells 2003 ·European Journal of Pharmacology ·Dennis Bruemmer, Fen Yin, Joey Liu, Tohru Kiyono, Eckart Fleck, (unknown), Kristof Graf, Ronald E. Law	16
10	TGF-β1 induces peroxisome proliferator-activated receptor γ1 and γ2 expression in human THP-1 monocytes 2002 ·Biochemical and Biophysical Research Communications ·Ulrich Kintscher, Shu Wakino, Dennis Bruemmer, Stephan Goetze, Kristof Graf, Willa A. Hsueh, Ronald E. Law	21
11	TNFα induces expression of transcription factors c-fos, Egr-1, and Ets-1 in vascular lesions through extracellular signal-regulated kinases 1/2 2001 ·Atherosclerosis ·Stephan Goetze, Ulrich Kintscher, (unknown), Woerner P. Meehan, Alan R. Collins, Eckart Fleck, Willa A. Hsueh, Ronald E. Law	118
12	Doxazosin Inhibits Monocyte Chemotactic Protein 1–Directed Migration of Human Monocytes 2001 ·Journal of Cardiovascular Pharmacology ·Ulrich Kintscher, (unknown), Shu Wakino, Stephan Goetze, Kristof Graf, Eckart Fleck, Willa A. Hsueh, Ronald E. Law	19
13	Peroxisome Proliferator-activated Receptor γ Ligands Inhibit Mitogenic Induction of p21Cip1 by Modulating the Protein Kinase Cδ Pathway in Vascular Smooth Muscle Cells 2001 ·Journal of Biological Chemistry ·Shu Wakino, Ulrich Kintscher, Zhaowei Liu, Sarah Kim-Hellmuth, Fen Yin, Motoi Ohba, Toshio Kuroki, Axel H. Schönthal, Willa A. Hsueh, Ronald E. Law	67
14	Insulin signaling in the arterial wall 1999 ·The American Journal of Cardiology ·Willa A. Hsueh, Ronald E. Law	166
15	Troglitazone inhibits angiotensin II‐induced extracellular signal‐regulated kinase 1/2 nuclear translocation and activation in vascular smooth muscle cells 1999 ·FEBS Letters ·Stephan Goetze, Xiao-Ping Xi, Kristof Graf, Eckart Fleck, Willa A. Hsueh, Ronald E. Law	56
16	Mitogen-Activated Protein Kinase Activation Mediates PDGF- Directed Migration of RPE Cells 1998 ·Experimental Cell Research ·David R. Hinton, Shikun He, Kristof Graf, Yang Dong, Willa A. Hsueh, Stephen J. Ryan, Ronald E. Law	63
17	Inhibition of MAP kinase blocks insulin‐mediated DNA synthesis and transcriptional activation of c‐fos by Elk‐1 in vascular smooth muscle cells 1997 ·FEBS Letters ·Xiao-Ping Xi, Kristof Graf, Stephan Goetze, Willa A. Hsueh, Ronald E. Law	53
18	Troglitazone inhibits angiotensin II‐induced DNA synthesis and migration in vascular smooth muscle cells 1997 ·FEBS Letters ·Kristof Graf, (unknown), Willa A. Hsueh, Ronald E. Law	65
19	Angiotensin II in Cell Growth and Matrix Production 1995 ·Advances in experimental medicine and biology ·Willa A. Hsueh, (unknown), Pamela W. Anderson, Ronald E. Law	35
20	Lipopolysaccharide-Induced NF-κB Activation in Mouse 70Z/3 Pre-B Lymphocytes Is Inhibited by Mevinolin and 5′-Methylthioadenosine: Roles of Protein Isoprenylation and Carboxyl Methylation Reactions 1992 ·Molecular and Cellular Biology ·Ronald E. Law, Julie B. Stimmel, Michael A. Damore, Carla Carter, Steven Clarke, Randolph Wall	10

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact